0001193125-15-087605.txt : 20150311 0001193125-15-087605.hdr.sgml : 20150311 20150311172352 ACCESSION NUMBER: 0001193125-15-087605 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 6 FILED AS OF DATE: 20150311 DATE AS OF CHANGE: 20150311 GROUP MEMBERS: TARSHISH HAHZAKOT VEHASHKAOT HAPOALIM LTD. SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: TOWER SEMICONDUCTOR LTD CENTRAL INDEX KEY: 0000928876 STANDARD INDUSTRIAL CLASSIFICATION: SEMICONDUCTORS & RELATED DEVICES [3674] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-45635 FILM NUMBER: 15693673 BUSINESS ADDRESS: STREET 1: RAMAT GAVRIEL INDUSTRIAL PARK STREET 2: PO BOX 619 CITY: MIGDAL HAEMEK STATE: L3 ZIP: 23105 BUSINESS PHONE: 97246506611 MAIL ADDRESS: STREET 1: RAMAT GAVRIEL INDUSTRIAL PARK STREET 2: PO BOX 619 CITY: MIGDAL HAEMEK STATE: L3 ZIP: 23105 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BANK HAPOALIM BM CENTRAL INDEX KEY: 0000902528 STANDARD INDUSTRIAL CLASSIFICATION: UNKNOWN SIC - 8880 [8880] IRS NUMBER: 132775750 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: 50 ROTHCHILD BOULEVARD CITY: TEL AVIV STATE: L3 ZIP: 00000 BUSINESS PHONE: 9723567494 MAIL ADDRESS: STREET 1: BANK HAPOALIM B M STREET 2: 50 ROTHCHILD BOULEVARD CITY: TEL AVIV STATE: L3 ZIP: 00000 SC 13D/A 1 d887643dsc13da.htm SC 13D/A SC 13D/A
Page 1 of 10

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 13D

Under the Securities Exchange Act of 1934

(Amendment No. 7)

 

 

Tower Semiconductor Ltd.

(Name of Issuer)

Ordinary Shares, NIS 15.00 par value per share

(Title of Class of Securities)

M87915-10-0

(CUSIP Number)

Ronen Meidan

Bank Hapoalim B.M.

63 Yehuda Halevi St.

Tel Aviv 6578109, Israel

972-3-567-4174

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

March 6, 2015

(Date of Event Which Requires Filing of This Statement)

 

 

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.  ¨

 

 

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent.

 

 

 

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

 

 

 


13D

 

CUSIP No. M87915-10-0 Page 2 of 10

 

  1. 

Names of reporting persons.

Bank Hapoalim B.M.

 

I.R.S. Identification Nos. of above persons (entities only).

Not applicable.

  2.

Check the appropriate box if a member of a group (see instructions)

(a)  ¨        (b)  x

 

  3.

SEC use only

 

  4.

Source of funds (see instructions)

 

    OO

  5.

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)    ¨

 

  6.

Citizenship or place of organization - Israel

 

Number of

shares

beneficially

owned by

each

reporting

person

with

 

  7. 

Sole voting power - 4,622,662

 

  8.

Shared voting power - 29,887

 

  9.

Sole dispositive power - 4,622,662

 

10.

Shared dispositive power - 29,887

 

11.

Aggregate amount beneficially owned by each reporting person - 4,652,549

 

12.

Check if the aggregate amount in Row (11) excludes certain shares (see instructions)    x

 

13.

Percent of class represented by amount in Row (11) - 6.7% (1)

 

14.

Type of reporting person (see instructions)

 

    BK

 

 

 

(1) Based on the number of Ordinary Shares outstanding as at February 15, 2015, as reported by Tower in its March 2, 2015 Proxy Statement filed with the Securities and Exchange Commission (the “Commission”) under cover of Form 6-K on March 2, 2015 (the “March 2015 Proxy Statement”), and calculated in accordance with rule 13d-3(d)(1)(i).

 

 

 

2


13D

 

CUSIP No. M87915-10-0 Page 3 of 10

 

  1. 

Names of reporting persons.

Tarshish Hahzakot Vehashkaot Hapoalim Ltd.

 

I.R.S. Identification Nos. of above persons (entities only).

Not applicable.

  2.

Check the appropriate box if a member of a group (see instructions)

(a)  ¨        (b)  x

 

  3.

SEC use only

 

  4.

Source of funds (see instructions)

 

    OO

  5.

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)    ¨

 

  6.

Citizenship or place of organization - Israel

 

Number of

shares

beneficially

owned by

each

reporting

person

with

 

  7. 

Sole voting power - 0

 

  8.

Shared voting power - 29,887

 

  9.

Sole dispositive power - 0

 

10.

Shared dispositive power - 29,887

 

11.

Aggregate amount beneficially owned by each reporting person - 29,887

 

12.

Check if the aggregate amount in Row (11) excludes certain shares (see instructions)    x

 

13.

Percent of class represented by amount in Row (11) - less than 0.01% (1)

 

14.

Type of reporting person (see instructions)

 

    CO

 

 

 

(1) Based on number of Ordinary Shares outstanding as at February 15, 2015, as reported by Tower to the Commission in its March 2015 Proxy Statement, and calculated in accordance with rule 13d-3(d)(1)(i).

 

 

 

3


13D

 

CUSIP No. M87915-10-0     Page 4 of 10

 

 

 

The statement on Schedule 13D, dated February 3, 2011, of Bank Hapoalim B.M. (“Hapoalim”) and Tarshish Hahzakot Vehashkaot Hapoalim Ltd. (“Tarshish”) (collectively, the “Reporting Persons”), as amended by Amendment No. 1 thereto, dated June 10, 2013, Amendment No. 2 thereto, dated June 24, 2013, Amendment No. 3 thereto, dated July 22, 2013, Amendment No. 4 thereto, dated January 15, 2014, Amendment No. 5 thereto, dated June 6, 2014, and Amendment No. 6 thereto, dated August 29, 2014, is hereby further amended as follows:

 

Item 2. Identity and Background

Schedule A is hereby amended to read in its entirety as attached hereto and incorporated by reference.

 

Item 5. Interest in Securities of the Issuer

Item 5(a)-(c) is hereby amended to read in its entirety as follows:

“To the knowledge of the Reporting Persons:

 

(a)     (1)  

Hapoalim is the beneficial owner of 4,652,549 Ordinary Shares, including 3,940,626 Ordinary Shares issuable upon conversion of its currently convertible capital notes, 170,374 Ordinary Shares issuable upon exercise of currently exercisable warrants (including warrants to purchase 140,487 Ordinary Shares held by Hapoalim and a warrant to purchase 29,887 Ordinary Shares held by Tarshish, its wholly-owned subsidiary) expiring on December 31, 2018 and 199,665 Series 9 Warrants expiring on June 27, 2017. Hapoalim (and Tarshish’s) ownership, as aforesaid collectively represents approximately 6.7% of the Ordinary Shares outstanding as at February 15, 2015, as reported by Tower to the Commission in its March 2015 Proxy Statement, and calculated in accordance with rule 13d-3(d)(1)(i).

    (2)  

Tarshish is the beneficial owner of 29,887 Ordinary Shares issuable upon exercise of its currently exercisable warrant, representing less than 0.01% of the Ordinary Shares outstanding as at February 15, 2015 as reported by Tower to the Commission in its March 2015 Proxy Statement, and calculated in accordance with rule 13d-3(d)(1)(i).

 

  (b) Hapoalim has sole voting and dispositive power over 4,622,662 Ordinary Shares, including 3,940,626 Ordinary Shares issuable upon conversion of currently convertible capital notes, 140,487 Ordinary Shares issuable upon exercise of currently exercisable warrants expiring on December 31, 2018 and 199,665 Series 9 Warrants expiring on June 27, 2017. Hapoalim and Tarshish share voting and dispositive power over 29,887 Ordinary Shares issuable upon exercise of a currently exercisable warrant held by Tarshish expiring on December 31, 2018.

 

  (c) Save for the following, neither Hapoalim nor Tarshish has effected any transactions in the Ordinary Shares during the past 60 days:

Set forth below are the dates of sale, number and average price per share of Ordinary Shares sold by Hapoalim on NASDAQ.

 

Date

   Number of Shares      Price Per Share  

January 6, 2015

     2,043       US $ 13.0615   

January 8, 2015

     20,000       US $ 13.0612   

January 12, 2015

     20,000       US $ 13.3894   

January 13, 2015

     20,000       US $ 13.4170   

January 14, 2015

     20,000       US $ 13.3660   

January 15, 2015

     20,000       US $ 13.4140   

January 20, 2015

     8,100       US $ 13.4842   

March 4, 2015

     80,000       US $ 17.7000   

March 5, 2015

     80,000       US $ 17.7300   

March 6, 2015

     80,000       US $ 17.6883   

March 9, 2015

     5,100       US $ 17.3000   

 

4


13D

 

CUSIP No. M87915-10-0     Page 5 of 10

 

 

 

Set forth below are the dates of sale, number and average price per warrant of Series 9 Warrants sold by Hapoalim in over-the-counter transactions not effected on any stock exchange. Each Series 9 Warrant permits the holder thereof to purchase an Ordinary Share at a price of US $7.33 per share until June 27, 2017. Although all sales were made in New Israel Sheqels (“NIS”), the U.S. Dollar Price set forth below reflects conversion of such NIS Price into U.S. Dollars based on the relevant Representative Rate published by the Bank of Israel:

 

Date

   Number of Series 9
Warrants
     Price Per Warrant  

January 28, 2015

     30,000       US $ 8.2741   

January 29, 2015

     50,000       US $ 8.7620   

March 3, 2015

     148,000       US $ 10.0628   

March 4, 2015

     10,000       US $ 10.6099   

 

Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer

 

1. The section entitled “Registration Rights Agreement” is hereby amended as follows:

 

1.1. In the first paragraph, subclause (c) of the last sentence thereof is hereby amended to read in its entirety as follows:

 

  “(c) upon exercise of any of the warrants issued to any of the Reporting Persons in 2003, 2005, 2007, 2009, 2010, 2011 and 2014 (see “Warrants” below).”

 

1.2. To add to the last paragraph thereof the following words “and the 2014 Amendment to the Amended and Restated Registration Rights Agreement between Tower and Hapoalim (Exhibit 18 to this Statement)” immediately before the words “which are each incorporated herein in their entirety by reference”.

 

2. The section entitled “Warrants” is hereby amended as follows:

 

2.1. The following paragraph is hereby added before the final paragraph:

“On October 27, 2014, in connection with a further amendment to the Facility Agreement which, inter alia, extended the Final Maturity Date thereunder to October 1, 2018, Tower (a) amended the 2003, 2007 and 2011 Warrants to extend the expiry date of each such Warrant to December 31, 2018; and (b) issued to Hapoalim a warrant to purchase 200,000 Ordinary Shares at a purchase price of US $10.50 per share, which may only be exercised during the period commencing January 1, 2017 and ending on December 31, 2018 (the “2014 Warrant”).”

 

5


13D

 

CUSIP No. M87915-10-0 Page 6 of 10

 

 

 

2.2. The final paragraph is hereby amended to read in its entirety as follows:

“The foregoing summary of the outstanding 2003, 2007, 2010 and 2014 Warrants is qualified in its entirety by reference to the Amended and Restated 2003 Warrant (Exhibit 5 to this Statement), the Amended and Restated 2007 Warrant (Exhibit 6 to this Statement), the 2011 Warrant (Exhibit 10 to this Statement), First Amendment to 2003 Warrant (Exhibit 11 to this Statement), First Amendment to 2007 Warrant (Exhibit 12 to this Statement), First Amendment to 2011 Warrant (Exhibit 13 to this Statement), Second Amendment to 2003 Warrant (Exhibit 14 to this Statement), Second Amendment to 2007 Warrant (Exhibit 15 to this Statement), Second Amendment to 2011 Warrant (Exhibit 16 to this Statement) and the 2014 Warrant (Exhibit 17 to this Statement).”

 

3. The section entitled “Facility Agreement” is hereby amended to delete the words “TIC” and “the Lead Investors” each time they appear and to substitute therefor the words “Kenon Holdings Ltd.” and to delete “60%” and substitute “30%” therefor.

 

Item 7. Material to be filed as Exhibits

Item 7 is hereby amended to add the following Exhibits:

 

14. Second Amendment, dated October 27, 2014, to Amended and Restated Warrant originally issued on December 11, 2003 by Tower Semiconductor Ltd. to Tarshish Hahzakot Vehashkaot Hapoalim Ltd.

 

15. Second Amendment, dated October 27, 2014, to Amended and Restated Warrant originally issued on September 10, 2007 by Tower Semiconductor Ltd. to Bank Hapoalim B.M.

 

16. Second Amendment, dated October 27, 2014, to Warrant issued on September 1, 2011 by Tower Semiconductor Ltd. to Bank Hapoalim B.M.

 

17. Warrant, dated October 27, 2014, granted by Tower Semiconductor Ltd. to Bank Hapoalim B.M.

 

18. 2014 Amendment, dated October 27, 2014, to Amended and Restated Registration Rights Agreement between Tower Semiconductor Ltd. and Bank Hapoalim B.M., dated September 25, 2008.

 

6


13D

 

CUSIP No. M87915-10-0 Page 7 of 10

 

 

 

Signature

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

March 11, 2015

Date
/s/ Dan Alexander Koller /s/ Ronen Meidan

 

Signature
Bank Hapoalim B.M.
Dan Alexander Koller, Head of Ronen Meidan, Head of
Financial Markets Division Equity Investments Unit

 

Name/Title

March 11, 2015

Date
/s/ Dan Alexander Koller /s/ Ronen Meidan

 

Signature

Tarshish Hahzakot Vehashkaot Hapoalim Ltd.

 

Dan Alexander Koller, Chairman of Board of Directors Ronen Meidan, Director

 

Name/Title

 

7


13D

 

CUSIP No. M87915-10-0     Page 8 of 10

 

 

 

SCHEDULE A

Information Regarding Senior Officers and Directors of Bank Hapoalim B.M.

Board of Directors

 

Name

  

Address

  

Principal Occupation

  

Citizenship

Yair Seroussi    63 Yehuda Halevi St., Tel Aviv, Israel    Chairman of the Board of Bank Hapoalim B.M.    Israel
Irit Izakson    63 Yehuda Halevi St., Tel Aviv, Israel    Chairman of the Boards of Directors of the credit-card companies in the Bank Group, director in various companies    Israel
Mali Baron    63 Yehuda Halevi St., Tel Aviv, Israel    Director of companies    Israel
Amnon Dick    63 Yehuda Halevi St., Tel Aviv, Israel    Businessman, partner in communications companies, consultant and director. CEO of Adsensory Ltd.    Israel
Meir Wietchner    63 Yehuda Halevi St., Tel Aviv, Israel    Head of Global strategy for the Arison Group and Chairman of the Miya Group    Israel
Nir Zichlinskey    63 Yehuda Halevi St., Tel Aviv, Israel    President and CEO of SRI Global Group    Israel
Imri Tov    63 Yehuda Halevi St., Tel Aviv, Israel    Director of companies; business consultant and researcher in defense economics    Israel
Yaacov Peer    63 Yehuda Halevi St., Tel Aviv, Israel    Financial and managerial consultant for small businesses    Israel
Efrat Peled    63 Yehuda Halevi St., Tel Aviv, Israel   

Chairman of the Board and CEO of the following companies: Arison Holdings (1998) Ltd.,

Arison Investments Ltd.,

Arison Sustainability Ltd.,

Arzaf Ltd., Arzaf B (97) Ltd., and Arzaf D Ltd. and CEO of the following companies: SAFO LLC and Arzaf C Ltd.

   Israel
Nehama Ronen    63 Yehuda Halevi St., Tel Aviv, Israel    Chairperson of the Board of Directors of Maman Cargo Terminals Ltd. and Recycling Corporation (ELA)    Israel
Moshe Koren    63 Yehuda Halevi St., Tel Aviv, Israel    Banking and financial consultant    Israel
Dafna Schwartz    63 Yehuda Halevi St., Tel Aviv, Israel    Professor and member of staff at the Department of Business Administration, Faculty of Management, Ben Gurion University of the Negev, Economic and business consultant in Israel and overseas    Israel
Ido Stern    63 Yehuda Halevi St., Tel Aviv, Israel    Deputy General Manager and legal counsel at Arison Holdings (1998) Ltd. and Arison Investments Ltd.    Israel
Yair Tauman    63 Yehuda Halevi St., Tel Aviv, Israel    Professor at the Interdisciplinary Center Herzliya and at the State University of New York at Stony Brook    Israel
Yosef Yarom    63 Yehuda Halevi St., Tel Aviv, Israel    Lecturer on auditing in the business sector at Haifa University    Israel & Argentina

 

8


13D

 

CUSIP No. M87915-10-0     Page 9 of 10

 

 

 

Senior Officers

 

Name

  

Business Address

  

Principal Occupation

  

Citizenship

Zion Kenan    63 Yehuda Halevi St., Tel Aviv, Israel    President and Chief Executive Officer    Israel
Ari Pinto    63 Yehuda Halevi St., Tel Aviv, Israel    Head of Retail Banking    Israel
Jacob Orbach    63 Yehuda Halevi St., Tel Aviv, Israel    Head of Corporate Banking    Israel
Efrat Yavetz    63 Yehuda Halevi St., Tel Aviv, Israel    Head of Human Capital, Advising, and Resources    Israel
Ofer Levy    63 Yehuda Halevi St., Tel Aviv, Israel    Chief Accountant    Israel
Dan Alexander Koller    63 Yehuda Halevi St., Tel Aviv, Israel    Head of Financial Markets    Israel
Ilan Mazur    63 Yehuda Halevi St., Tel Aviv, Israel    Chief Legal Adviser    Israel
Yadin Antebi    63 Yehuda Halevi St., Tel Aviv, Israel    Chief Financial Officer    Israel
Ron Weksler    63 Yehuda Halevi St., Tel Aviv, Israel    Head of Corporate Strategy    Israel
Amir Aviv    63 Yehuda Halevi St., Tel Aviv, Israel    Head of International Banking    Israel
Zeev Chayu    63 Yehuda Halevi St., Tel Aviv, Israel    Head of Internal Audit in Israel and abroad    Israel
Yoram Weissbrem    63 Yehuda Halevi St., Tel Aviv, Israel    Corporate Secretary    Israel
Tsahi Cohen    63 Yehuda Halevi St., Tel Aviv, Israel    Chief Risk Officer    Israel
Avi Kochva    63 Yehuda Halevi St., Tel Aviv, Israel    Head of Information Technology    Israel
        

PRINCIPAL HOLDERS OF THE

ISSUED SHARE CAPITAL OF BANK HAPOALIM B.M.

 

NAME

   % OF CAPITAL  

ARISON HOLDINGS (1998) LTD

     20.2

SALT OF THE EARTH LTD

     0.6

 

9


13D

 

CUSIP No. M87915-10-0     Page 10 of 10

 

 

 

Arison Holdings (1998) Ltd. - Director Information

 

Name

  

Address

  

Citizenship

  

Principal Occupation

Irit Izakson    63 Yehuda Halevi St., Tel-Aviv, Israel    Israel    director in various companies
Shari Arison    23 Shaul Hamelech Blvd., Tel-Aviv, Israel    Israel & USA    Investor
James M. Dubin    c/o Paul Weiss, 1285 Avenue of the Americas, New York, NY    USA    Attorney - Paul Weiss
Jason Arison    23 Shaul Hamelech Blvd., Tel-Aviv, Israel    Israel & USA    Chairman, The Ted Arison Family Foundation (Israel) Ltd.
David Arison    23 Shaul Hamelech Blvd., Tel-Aviv, Israel    Israel & USA    Officer of MIYA, an Arison Group Company
Cassie Arison    23 Shaul Hamelech Blvd., Tel-Aviv, Israel    Israel & USA    Investor
Efrat Peled    23 Shaul Hamelech Blvd., Tel-Aviv, Israel    Israel    Chairman of the Board and CEO of Arison Holdings (1998) Ltd., CEO and director in various companies
Daniel Arison    23 Shaul Hamelech Blvd., Tel-Aviv, Israel    Israel & USA    Investor

Salt Of The Earth Ltd. - Director Information

 

Name

  

Address

  

Citizenship

  

Principal Occupation

Efrat Peled    23 Shaul Hamelech Blvd., Tel-Aviv, Israel    Israel    Chairman of the Board and CEO - Arison Holdings (1998) Ltd., CEO and director in various companies
Dovik Tal    Atlit, Israel    Israel    CEO - Israel Salt Industries Ltd.
Moshe Lahmani    23 Shaul Hamelech Blvd., Tel-Aviv, Israel    Israel    CFO - Arison Holdings (1998) Ltd.
Ido Stern    63 Yehuda Halevi St., Tel Aviv, Israel    Israel    Deputy General Manager and legal counsel at Arison Holdings (1998) Ltd. and Arison Investments Ltd.

Information Regarding Senior Officers and Directors

of Tarshish Hahzakot Vehashkaot Hapoalim Ltd.

Board of Directors

 

Name

  

Address

  

Principal Occupation

  

Citizenship

Eran Zimmerman    11 Hanegev St., Tel-Aviv, Israel    CEO (Tarshish). SVP capital management - Bank Hapoalim B.M.    Israel
Dan Alexander Koller    63 Yehuda Halevi St., Tel Aviv, Israel    Head of Financial Markets - Bank Hapoalim B.M.    Israel
Yoram Weissbrem    63 Yehuda Halevi St., Tel Aviv, Israel    Corporate Secretary of Bank Hapoalim B.M.    Israel
Ronen Meidan    63 Yehuda Halevi St., Tel Aviv, Israel    Head of Equity Investment Unit- Bank Hapoalim B.M.    Israel
Arie Stainfeld    62 Yehuda Halevi St., Tel Aviv, Israel    Head of Exposures and Risk Management Department- Bank Hapoalim B.M.    Israel
Guy Kalif, C.P.A. (Isr)    11 Hanegev St., Tel-Aviv, Israel    Manager, Comptroller Division - Bank Hapoalim B.M.    Israel

 

10

EX-14 2 d887643dex14.htm EX-14 EX-14

Exhibit 14

SECOND AMENDMENT

to

AMENDED AND RESTATED

WARRANT ORIGINALLY

ISSUED ON DECEMBER 11, 2003

 

 

THIS SECOND AMENDMENT is made on the 27th day of October, 2014, between:

 

  (1) TOWER SEMICONDUCTOR LTD., a company incorporated in Israel (registered number 52–004199–7), having its registered office at P.O. Box 619, Migdal Haemek 23105, Israel (“the Company”);

and

 

  (2) TARSHISH HAHZAKOT VEHASHKAOT HAPOALIM LTD. (“the Holder”)

WHEREAS:

 

(A) pursuant to a Warrant issued on December 11, 2003, the Company granted the Holder the right to purchase 448,298 (four hundred and forty-eight thousand two hundred and ninety-eight) Warrant Shares at the Warrant Price of US $6.17 (six United States Dollars and seventeen cents) per share, such Warrant being amended on September 28, 2006, October 13, 2009 and August 16, 2010 and amended and restated in its entirety on September 1, 2010 and further amended on March 13, 2013 (such Warrant as amended and restated as aforesaid, “the Restated Warrant”); and

 

(B) as a result of a 15 to 1 reverse stock split effected by the Company in August 2012, the number of Warrant Shares has been adjusted to 29,887 (twenty-nine thousand eight hundred and eighty-seven) and the Warrant Price has been adjusted to US $92.55 (ninety-two United States Dollars and fifty-five cents); and

 

(C) at the request of the Company, the Company and the Holder have agreed to enter into this Second Amendment to the Restated Warrant, dated as of the date hereof (“this Amendment”), in order to extend the Expiration Date of the Restated Warrant,

 

1


NOW THEREFORE IT IS AGREED BETWEEN THE PARTIES HERETO AS FOLLOWS:

 

1. Unless otherwise defined in this Amendment, terms defined and references contained in the Restated Warrant, shall have the same meaning and construction in this Amendment.

 

2. The Restated Warrant is hereby amended as follows:

Clause 2A (“Term”) is hereby amended to delete the date “December 31, 2016” and substitute therefor the date “December 31, 2018”.

 

3. Save as amended expressly pursuant to this Amendment, the provisions of the Restated Warrant shall continue in full force and effect and the Restated Warrant and this Amendment shall be read and construed as one instrument.

 

4. This Amendment shall be governed by and construed in accordance with the laws of the State of Israel.

IN WITNESS WHEREOF, the parties have signed this Second Amendment on the 27th day of October, 2014.

 

for: TOWER SEMICONDUCTOR LTD.
By: /s/ Oren Shirazi /s/ Yoram Glatt
 

 

Title CFO Treasurer
 

 

for: TARSHISH HAHZAKOT
VEHASHKAOT HAPOALIM LTD.
By: /s/ Ronen Meidan /s/ Eran Zimmerman
 

 

Title Director CEO
 

 

 

2

EX-15 3 d887643dex15.htm EX-15 EX-15

Exhibit 15

SECOND AMENDMENT

to

AMENDED AND RESTATED

WARRANT ORIGINALLY

ISSUED ON SEPTEMBER 10, 2007

 

 

THIS SECOND AMENDMENT is made on the 27th day of October, 2014, between:

 

  (1) TOWER SEMICONDUCTOR LTD., a company incorporated in Israel (registered number 52–004199–7), having its registered office at P.O. Box 619, Migdal Haemek 23105, Israel (“the Company”);

and

 

  (2) BANK HAPOALIM B.M. (“the Holder”)

WHEREAS:

 

(A) pursuant to a Warrant issued on September 10, 2007, the Company granted the Holder the right to purchase 1,470,588 (one million four hundred and seventy thousand five hundred and eighty-eight) Warrant Shares at the Warrant Price of US $2.04 (two United States Dollars and four cents) per share, such Warrant being amended on October 13, 2009 and August 16, 2010 and amended and restated in its entirety on September 1, 2010 and further amended on March 13, 2013 (such Warrant as amended and restated as aforesaid, “the Restated Warrant”); and

 

(B) as a result of a 15 to 1 reverse stock split effected by the Company in August 2012, the number of Warrant Shares has been adjusted to 98,040 (ninety-eight thousand and forty) and the Warrant Price has been adjusted to US $30.60 (thirty United States Dollars and sixty cents); and

 

(C) at the request of the Company, the Company and the Holder have agreed to enter into this Second Amendment to the Restated Warrant, dated as of the date hereof (“this Amendment”), in order to extend the Expiration Date of the Restated Warrant,

 

1


NOW THEREFORE IT IS AGREED BETWEEN THE PARTIES HERETO AS FOLLOWS:

 

1. Unless otherwise defined in this Amendment, terms defined and references contained in the Restated Warrant, shall have the same meaning and construction in this Amendment.

 

2. The Restated Warrant is hereby amended as follows:

Clause 2A (“Term”) is hereby amended to delete the date “December 31, 2016” and substitute therefor the date “December 31, 2018”.

 

3. Save as amended expressly pursuant to this Amendment, the provisions of the Restated Warrant shall continue in full force and effect and the Restated Warrant and this Amendment shall be read and construed as one instrument.

 

4. This Amendment shall be governed by and construed in accordance with the laws of the State of Israel.

IN WITNESS WHEREOF, the parties have signed this Second Amendment on the 27th day of October, 2014.

 

for: TOWER SEMICONDUCTOR LTD.
By: /s/ Oren Shirazi /s/ Yoram Glatt
 

 

Title CFO Treasurer
 

 

for: BANK HAPOALIM B.M.
By: /s/ Irit Beahar /s/ Irit Sigman
 

 

Title Department Manager Section Manager
 

 

 

2

EX-16 4 d887643dex16.htm EX-16 EX-16

Exhibit 16

SECOND AMENDMENT

to

WARRANT ISSUED ON

SEPTEMBER 1, 2011

 

 

THIS SECOND AMENDMENT is made on the 27th day of October, 2014, between:

 

  (1) TOWER SEMICONDUCTOR LTD., a company incorporated in Israel (registered number 52–004199–7), having its registered office at P.O. Box 619, Migdal Haemek 23105, Israel (“the Company”);

and

 

  (2) BANK HAPOALIM B.M. (“the Holder”)

WHEREAS:

 

(A) pursuant to a Warrant issued on September 1, 2011 and amended on March 13, 2013 (“the Warrant”), the Company granted the Holder the right to purchase 636,699 (six hundred and thirty-six six hundred and ninety-nine) Warrant Shares at the Warrant Price of US $0.7853 (zero point seven eight five three United States Dollars) (but not less than NIS 1.00 per share) per share; and

 

(B) as a result of a 15 to 1 reverse stock split effected by the Company in August 2012, the number of Warrant Shares has been adjusted to 42,447 (forty-two thousand four hundred and forty-seven) and the Warrant Price has been adjusted to US $11.7795 (eleven United States Dollars and seventy-seven point ninety-five cents); and

 

(C) at the request of the Company, the Company and the Holder have agreed to enter into this Second Amendment to the Warrant, dated as of the date hereof (“this Amendment”), in order to extend the Expiration Date of the Warrant,

 

1


NOW THEREFORE IT IS AGREED BETWEEN THE PARTIES HERETO AS FOLLOWS:

 

1. Unless otherwise defined in this Amendment, terms defined and references contained in the Warrant, shall have the same meaning and construction in this Amendment.

 

2. The Warrant is hereby amended as follows:

Clause 2A (“Term”) is hereby amended to delete the date “December 31, 2016” and substitute therefor the date “December 31, 2018”.

 

3. Save as amended expressly pursuant to this Amendment, the provisions of the Warrant shall continue in full force and effect and the Warrant and this Amendment shall be read and construed as one instrument.

 

4. This Amendment shall be governed by and construed in accordance with the laws of the State of Israel.

IN WITNESS WHEREOF, the parties have signed this Second Amendment on the 27th day of October, 2014.

 

for: TOWER SEMICONDUCTOR LTD.
By: /s/ Oren Shirazi /s/ Yoram Glatt
 

 

Title CFO Treasurer
 

 

for: BANK HAPOALIM B.M.
By: /s/ Irit Beahar /s/ Irit Sigman
 

 

Title Department Manager Section Manager
 

 

 

2

EX-17 5 d887643dex17.htm EX-17 EX-17

Exhibit 17

THIS WARRANT HAS NOT BEEN REGISTERED OR QUALIFIED UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (“THE ACT”), OR ANY U.S. STATE OR OTHER JURISDICTION’S SECURITIES LAWS. THIS WARRANT, AND THE SECURITIES ISSUABLE PURSUANT THERETO, MAY NOT BE SOLD, OFFERED FOR SALE OR PLEDGED, HYPOTHECATED OR OTHERWISE TRANSFERRED IN THE ABSENCE OF A REGISTRATION STATEMENT IN EFFECT UNDER THE ACT WITH RESPECT TO THIS WARRANT OR THE SECURITIES ISSUABLE PURSUANT THERETO OR AN OPINION OF COUNSEL (REASONABLY SATISFACTORY TO THE COMPANY) THAT SUCH REGISTRATION IS NOT REQUIRED OR UNLESS SOLD PURSUANT TO RULE 144 OF THE ACT OR ON THE TEL-AVIV STOCK EXCHANGE IN COMPLIANCE WITH REGULATION S UNDER THE ACT.

WARRANT TO PURCHASE ORDINARY SHARES

Tower Semiconductor Ltd., an Israeli company (“the Company”), whose shares are currently traded on Nasdaq and the Tel-Aviv Stock Exchange (“TASE”) hereby grants to BANK HAPOALIM B.M. (“the Holder”), the right to purchase from the Company the number of Ordinary Shares of the Company, nominal value NIS 15.00 (fifteen New Israel Sheqels) (“the Ordinary Shares”) specified below, subject to the terms and conditions set forth below, effective as of October 27, 2014.

 

1. NUMBER OF ORDINARY SHARES AVAILABLE FOR PURCHASE

This Warrant may be exercised to purchase 200,000 (two hundred thousand) of the Company’s Ordinary Shares, with each Ordinary Share having a value calculated as set forth in Section 2 below, subject to adjustment under Section 7 of this Warrant (“the Warrant Shares”).

 

2. EXERCISE PRICE

The exercise price for each Warrant Share purchasable hereunder shall be, subject to adjustment under Section 7 of this Warrant, US $10.50 (ten US Dollars and fifty cents) (but not less than par value) per share (“the Warrant Price”).


2A. TERM

This Warrant may be exercised in whole during the period beginning from January 1, 2017 and ending on December 31, 2018 (“the Expiration Date”).

 

3. EXERCISE OF WARRANT

This Warrant may be exercised in whole or in part, on one or more occasions during its term. The Warrant may be exercised by the surrender of the Warrant to the Company at its principal office together with the Notice of Exercise annexed hereto duly completed and executed on behalf of the Holder.

 

  (a) Exercise for Cash

To exercise for cash, the Notice of Exercise must be accompanied by payment in full of the amount of the aggregate purchase price of the Warrant Shares being purchased upon such exercise in immediately available funds.

 

  (b) Net Exercise

In lieu of the payment method set forth in Section 3(a) above, the Holder may elect to exchange the Warrant for a number of Warrant Shares equal to the increase in value of the Warrant Shares otherwise purchasable hereunder on the date of exchange. If the Holder elects to exchange this Warrant as provided in this Section 3(b), the Holder shall tender to the Company the Warrant along with the Notice of Exercise and the Company shall issue to the Holder the number of Warrant Shares computed using the following formula:

where:

 

X = Y ( A – B )
          A

 

X = the number of Warrant Shares to be issued to the Holder;
Y = the number of Warrant Shares purchasable under this Warrant (as adjusted to the date of such calculation, but excluding those Ordinary Shares already issued under this Warrant or Warrant Shares purchasable under this Warrant but not being exercised);

 

2


A = the Fair Market Value (as defined below) of 1 (one) Ordinary Share; and
B = Warrant Price (as adjusted to the date of such calculation).

“Fair Market Value” of an Ordinary Share shall mean:

 

  (i) if the Ordinary Shares are listed on a national securities exchange or are quoted on the Nasdaq Global Market (NASDAQ/NGS) (“NASDAQ”), then the closing or last sale price, respectively, reported on the last trading day immediately preceding the exercise date, as reported by NASDAQ or the principal national securities exchange upon which the Ordinary Shares are listed or traded; provided that, if the Ordinary Shares are listed on NASDAQ and another national securities exchange, the applicable price shall be the price reported by NASDAQ;

 

  (ii) if the Ordinary Shares are not listed on a national securities exchange or quoted on NASDAQ, but are traded in the over-the-counter market, then the mean of the closing bid and asked prices as reported on the last trading day immediately preceding the exercise date;

 

  (iii) if the Ordinary Shares are not publicly traded, then as determined by the Company’s Board of Directors in good faith.

The exchange of this Warrant as provided in this Section 3(b) may not be utilized on more than 3 (three) occasions.

 

  (c) Issuance of Shares on Exercise

The Company agrees that the Warrant Shares so purchased shall be issued as soon as practicable thereafter, and that the Holder shall be deemed the record owner of such Warrant Shares as of and from the close of business on the date on which this Warrant shall be surrendered, together with payment in full as required above. In the event of a partial exercise, the Company shall concurrently issue to the Holder a replacement Warrant on the same terms and conditions as this Warrant, but representing the number of Warrant Shares remaining after such partial exercise.

 

3


4. FRACTIONAL INTEREST

No fractional shares will be issued in connection with any exercise hereunder, but in lieu of such fractional shares, the Company shall make a cash payment therefor upon the basis of the current market price of such shares then in effect as determined in good faith by the Company’s Board of Directors.

 

5. WARRANT CONFERS NO RIGHTS OF SHAREHOLDER

Except as otherwise set forth in this Warrant, the Holder shall not have any rights as a shareholder of the Company with regard to the Warrant Shares prior to actual exercise resulting in the purchase of any Warrant Shares.

 

6. INVESTMENT REPRESENTATION

Neither this Warrant nor the Warrant Shares issuable upon the exercise of this Warrant have been registered under the Securities Act, or any other securities laws. The Holder acknowledges by acceptance of the Warrant that (a) it has acquired this Warrant for investment and not with a view to distribution; (b) it has either a pre-existing personal or business relationship with the Company, or its executive officers, or by reason of its business or financial experience, it has the capacity to protect its own interests in connection with the transaction; and (c) it is an accredited investor as that term is defined in Regulation D promulgated under the Securities Act. The Holder agrees that any Warrant Shares issuable upon exercise of this Warrant will be acquired for investment and not with a view to distribution and that such Warrant Shares may have to be held indefinitely unless they are subsequently registered or qualified under the Securities Act and applicable state securities laws, or based on an opinion of counsel reasonably satisfactory to the Company, an exemption from such registration and qualification is available. The Holder, by acceptance hereof, consents to the placement of legend(s) on all securities hereunder as to the applicable restrictions on transferability in order to ensure compliance with the Securities Act, unless in the opinion of counsel for the Company such legend is not required in order to ensure compliance with the Securities Act. The Company may issue stop transfer instructions to its transfer agent in connection with such restrictions.

 

4


7. ADJUSTMENT OF WARRANT PRICE AND NUMBER OF SHARES

The number and kind of securities purchasable initially upon the exercise of this Warrant and the Warrant Price shall be subject to adjustment from time to time upon the occurrence of certain events, as follows:

 

  (a) Adjustment for Shares Splits and Combinations

If the Company at any time or from time to time effects a subdivision of the outstanding Ordinary Shares, the number of Warrant Shares issuable upon exercise of this Warrant immediately before the subdivision shall be proportionately increased, and conversely, if the Company at any time or from time to time combines the outstanding Ordinary Shares, the number of Warrant Shares issuable upon exercise of this Warrant immediately before the combination shall be proportionately decreased. Any adjustment under this Section 7(a) shall become effective at the close of business on the date the subdivision or combination becomes effective.

 

  (b) Adjustment for Certain Dividends and Distributions

In the event the Company at any time, or from time to time, makes or fixes a record date for the determination of holders of Ordinary Shares entitled to receive a dividend or other distribution payable in additional shares of Ordinary Shares, then and in each such event, the number of Ordinary Shares issuable upon exercise of this Warrant shall be increased as of the time of such issuance or, in the event such a record date is fixed, as of the close of business on such record date, by multiplying the number of Ordinary Shares issuable upon exercise of this Warrant by a fraction: (i) the numerator of which shall be the total number of Ordinary Shares issued and outstanding immediately prior to the time of such issuance or the close of business on such record date plus the number of Ordinary Shares issuable in payment of such dividend or distribution; and (ii) the denominator of which is the total number of Ordinary Shares issued and outstanding immediately prior to the time of such issuance or the close of business on such record date; provided, however, that if such record date is fixed and such dividend is not fully paid or if such distribution is not fully made on the date fixed thereof, the number of Ordinary Shares issuable upon exercise of this Warrant shall be recomputed accordingly as of the close of business on such record date and thereafter the number of Ordinary Shares issuable upon exercise of this Warrant shall be adjusted pursuant to this Section 7(b) as of the time of the actual payment of such dividends or distribution.

 

5


  (c) Adjustments for Other Dividends and Distributions

In the event the Company at any time or from time to time makes, or fixes a record date for the determination of holders of Ordinary Shares entitled to receive a dividend or other distribution payable in securities of the Company other than Ordinary Shares, then in each such event provision shall be made so that the Holder shall receive upon exercise of this Warrant, in addition to the number of Ordinary Shares receivable thereupon, the amount of securities of the Company that the Holder would have received had this Warrant been exercised for Ordinary Shares immediately prior to such event (or the record date for such event) and had the Holder thereafter, during the period from the date of such event to and including the date of exercise, retained such securities receivable by it as aforesaid during such period, subject to all other adjustments called for during such period under this Section and the Company’s Articles of Association with respect to the rights of the Holder.

 

  (d) Adjustment for Reclassification, Exchange and Substitution

If the Ordinary Shares issuable upon the exercise of this Warrant are changed into the same or a different number of shares of any class or classes of shares, whether by recapitalization, reclassification or otherwise (other than a subdivision or combination of shares or shares dividend or a reorganization, merger, consolidation or sale of assets, provided for elsewhere in this Section), then and in any such event the Holder shall have the right thereafter to exercise this Warrant into the kind and amount of shares and other securities receivable upon such recapitalization, reclassification or other change, by holders of the number of shares of Ordinary Shares for which this Warrant might have been exercised immediately prior to such recapitalization, reclassification or change, all subject to further adjustment as provided herein and under the Company’s Articles of Association.

 

  (e) Reorganization, Mergers, Consolidations or Sales of Assets

If at any time or from time to time there is a capital reorganization of the Ordinary Shares (other than a recapitalization, subdivision, combination, reclassification or exchange of shares as provided for elsewhere in this subsection), or a merger or consolidation of the Company with or into another corporation, or the sale of all or substantially all of the Company’s properties and assets to any other person, then, as a part of such reorganization, merger, consolidation or sale, provision shall be made so that the Holder shall thereafter be entitled to receive upon exercise of this Warrant, the number of shares or other securities or property of the Company, or of the successor corporation resulting from such merger or consolidation or sale, to which a holder of Ordinary Shares deliverable upon conversion would have been entitled on such capital reorganization, merger, consolidation or sale. In any such case (except to the extent any cash or property is received in such transaction), appropriate adjustment shall be made in the application of the provisions of this subsection and the Company’s Articles of Association with respect to the rights of the Holder after the reorganization, merger, consolidation or sale to the end that the provisions of this subsection and the Company’s Articles of Association (including adjustment of the number of Ordinary Shares issuable upon exercise of this Warrant) shall be applicable after that event and be as nearly equivalent to the provisions hereof as may be practicable.

 

6


  (f) Other Transactions

In the event that the Company shall issue shares to its shareholders as a result of a split-off, spin-off or the like, then the Company shall only complete such issuance or other action if, as part thereof, allowance is made to protect the economic interest of the Holder either by increasing the number of Warrant Shares or by procuring that the Holder shall be entitled, on economically proportionate terms, to acquire additional shares of the spun-off or split-off entities.

 

  (g) Rights Offerings

If the Company, at any time and from time to time, shall fix a record date for, or shall make a distribution to, its shareholders of rights or warrants to subscribe for or purchase any security (collectively, “Rights”), then, in each such event, the Company will provide the Holder, concurrently with the distribution of the Rights to its shareholders, identical rights, having terms and conditions identical to the Rights (for the avoidance of doubt, exercisable at the same time as the Rights), in such number to which the Holder would be entitled had the Holder exercised this Warrant in full immediately prior to the record date for such distribution, or if no record date shall be fixed, then immediately prior to such distribution, as applicable. Nothing in this Section 7 shall require the Company to complete any such distribution of Rights to its shareholders, including following the record date thereof, unless required pursuant to the terms of such distribution and, if such distribution of Rights to its shareholders is not completed in conformity with the terms of such distribution, then the Company shall be entitled not to complete the provision of rights to the Holder pursuant to this Section 7(g) above.

 

7


  (h) General Protection

The Company will not, by amendment of its Articles of Association or other charter document or through any reorganization, recapitalization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms to be observed or performed hereunder, or impair the economic interest of the Holder, but will at all times in good faith assist in the carrying out of all the provisions hereof and in taking of all such actions and making all such adjustments as may be necessary or appropriate in order to protect the rights and the economic interests of the Holder against impairment.

 

  (i) Notice of Capital Changes

If at any time the Company shall offer for subscription pro rata to the holders of Ordinary Shares any additional shares of any class, other rights or any equity security of any kind, or there shall be any capital reorganization or reclassification of the capital shares of the Company, or consolidation or merger of the Company with, or sale of all or substantially all of its assets to another company or there shall be a voluntary or involuntary dissolution, liquidation or winding-up of the Company, or other transaction described in this Section 7, then, in any one or more of the said cases, the Company shall give the Holder written notice, by registered or certified mail, postage prepaid, of the date on which: (i) a record shall be taken for such subscription rights; or (ii) such reorganization, reclassification, consolidation, merger, sale, dissolution, liquidation or winding-up shall take place, as the case may be. Such notice shall also specify the date as of which the holders of record of Ordinary Shares shall participate in such subscription rights, or shall be entitled to exchange their Ordinary Shares for securities or other property deliverable upon such reorganization, reclassification, consolidation, merger, sale, dissolution, liquidation or winding-up, as the case may be. Such written notice shall be given at least 14 (fourteen) days prior to the action in question and not less than 14 (fourteen) days prior to the record date in respect thereto.

 

8


  (j) Adjustment of Warrant Price

Upon each adjustment in the number of Ordinary Shares purchasable hereunder, the Warrant Price shall be proportionately increased or decreased, as the case may be, in a manner that is the inverse of the manner in which the number of Ordinary Shares purchasable hereunder shall be adjusted.

 

  (k) Notice of Adjustments

Whenever the Warrant Price or the number of Ordinary Shares purchasable hereunder shall be adjusted pursuant to Section 7 hereof, the Company shall prepare a certificate signed by the chief financial officer of the Company setting forth, in reasonable detail, the event requiring the adjustment, the amount of the adjustment, the method by which such adjustment was calculated, and the Warrant Price and the number of Ordinary Shares purchasable hereunder after giving effect to such adjustment, and shall cause copies of such certificate to be mailed (by first class mail, postage prepaid) to the Holder.

 

8. TRANSFER OF THIS WARRANT OR SHARES

ISSUABLE ON EXERCISE HEREOF

 

  (a) With respect to any offer, sale or other disposition of this Warrant, the Holder will give written notice to the Company prior thereto, describing briefly the manner thereof, together with, if reasonably requested by the Company, a written opinion of such Holder’s counsel, to the effect that such offer, sale or other distribution may be effected without registration or qualification (under any federal or state law then in effect); provided, however, that no legal opinion shall be required if the transfer will be effected on TASE and the Holder represents to the Company that the applicable conditions under Regulation S under the Securities Act have been satisfied and applicable statutory lock-ups under the Israeli Securities Law do not apply or are being or have been satisfied or unless sold pursuant to Rule 144 of the Securities Act. If the proposed transfer is intended to rely on a Regulation D exemption under the Securities Act, such opinion letter and all such transferees must warrant and represent that they are an “accredited” investor as that term is defined under Regulation D of the Securities Act. Promptly, as practicable, upon receiving such written notice and opinion and warranties and representations, if so requested, the Company, as promptly as practicable, shall deliver to the Holder one or more replacement Warrant certificates on the same terms and conditions as this Warrant for delivery to the transferees. Each Warrant thus transferred and each certificate representing the securities thus transferred shall bear legend(s) as to the applicable restrictions on transferability in order to ensure compliance with the Securities Act, unless in the opinion of counsel for the Company such legend is not required in order to ensure compliance with the Securities Act. The Company may issue stop transfer instructions to its transfer agent in connection with such restrictions. Any provision of this Warrant to the contrary notwithstanding, the Holder may not offer, sell or otherwise dispose of this Warrant to any third party, other than: (i) to a wholly owned subsidiary of Bank Hapoalim or (ii) to any other transferee approved by the Company in writing with such approval not to be unreasonably withheld.

 

  (b) In the event that the Company or its shareholders receive an offer to transfer all or substantially all of the shares in the Company, or to effect a merger or acquisition or sale of all or substantially all of the assets of the Company, then the Company shall promptly inform the Holder in writing of such offer.

 

9


9. REGISTRATION RIGHTS

The Company covenants and agrees to provide the Holder the registration rights provided in the registration rights agreement between the Company and Bank Hapoalim B.M., dated September 28, 2006, as amended and restated by the parties on September 25, 2008, as further amended on October 13, 2009, and as further amended on October 27, 2014, a copy of which is attached hereto as Appendix A, and as such may be further amended from time to time (“the Registration Rights Agreement”). Such registration rights may be assigned by the Holder pursuant to and in accordance with the terms of the Registration Rights Agreement but only to a transferee or assignee of this Warrant pursuant to and in accordance with Section 8 of this Warrant.

 

10. REPRESENTATIONS, WARRANTIES AND COVENANTS

The Company represents, warrants and covenants to the Holder as follows:

 

  (a) this Warrant has been duly authorized and executed by the Company and is a valid and binding obligation of the Company enforceable in accordance with its terms;

 

10


  (b) the Warrant Shares are duly authorized and reserved for issuance by the Company and, when issued in accordance with the terms hereof, will be validly issued, fully paid and non-assessable and not subject to any pre-emptive rights;

 

  (c) the execution and delivery of this Warrant are not, and the issuance of the Warrant Shares upon exercise of this Warrant in accordance with the terms hereof will not be, inconsistent with the Company’s Certificate of Incorporation, Memorandum of Association or Articles of Association, do not and will not contravene any law, governmental rule or regulation, judgment or order applicable to the Company and, except for consents that have already been obtained by the Company, do not and will not conflict with or contravene any provision of, or constitute a default under, any indenture, mortgage, contract or other instrument of which the Company is a party or by which it is bound or require the consent or approval of, the giving of notice to, the registration with or the taking of any action in respect of or by, any federal, state or local governmental authority or agency or other person;

 

  (d) that it shall, upon the request of the Holder, procure the approvals required in order to list the Warrant Shares for trading on TASE; and

 

  (e) the representations and warranties set forth in Section 3.8 of the Conversion Agreement, dated September 25, 2008, between the Company and the Holder are true and correct on the date hereof as if made on the date hereof, the Company acknowledging that the Holder is acquiring the Warrant in full reliance upon the representations and warranties made by the Company in this Warrant, including this Section 10(e).

 

11. MISCELLANEOUS

In this Warrant:

 

  (a) Words importing the singular shall include the plural and vice versa and words importing any gender shall include all other genders and references to persons shall include partnerships, corporations and unincorporated associations.

 

11


  (b) Any reference in this Warrant to a specific form or to any rule or regulation adopted by the SEC shall also include any successor form or amended or successor rule or regulation subsequently adopted by the SEC, all as the same may be in effect at the time.

 

  (c) Any reference in this Agreement to a statute, act or law shall be construed as a reference to such statute, act or law as the same may have been, or may from time to time be, amended or reenacted.

 

  (d) A “person” shall be construed as a reference to any person, firm, company, corporation, government, state or agency of a state or any association or partnership (whether or not having separate legal personality) or two or more of the aforegoing.

 

  (e) “Including” and “includes” means, including, without limiting the generality of any description preceding such terms.

 

  (f) The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect any of the provisions hereof.

 

12. LOSS, THEFT, DESTRUCTION OR MUTILATION OF WARRANT

Upon receipt by the Company of evidence reasonably satisfactory to it of the loss, theft, destruction or mutilation of any Warrant or Shares certificate, and in case of loss, theft or destruction, of indemnity, or security reasonably satisfactory to it, and upon reimbursement to the Company of all reasonable expenses incidental thereto, and upon surrender and cancellation of such Warrant or Shares certificate, if mutilated, the Company will make and deliver a new Warrant or Shares certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or Shares certificate, provided that if this Warrant has been amended, at the request of the Holder, the Company shall issue an amended and restated Warrant certificate reflecting such amendment or amendments. In addition, but without derogating from the aforesaid, if this Warrant has been amended, the Holder shall have the right, at the option of the Holder, at any time and, if applicable, from time to time, to surrender this Warrant certificate and receive an amended and restated Warrant certificate reflecting any such amendment or amendments.

 

12


13. NOTICES

Any notice or other communication hereunder shall be in writing and shall be deemed to have been given upon delivery, if personally delivered or 3 (three) business days after deposit if deposited in the mail for mailing by certified mail, postage prepaid, and addressed as follows:

 

If to the Holder: Bank Hapoalim B.M.
Corporate Division
Migdal Levenstein
23 Menachem Begin Road
Tel-Aviv
Attention: Head of Special
Credits Division
Facsimile: (03) 567-4719
If to the Company: Tower Semiconductor Ltd.
P.O. Box 619
Ramat Gabriel Industrial Zone
Migdal Haemek 23105
Israel
Attention: Oren Shirazi
Chief Financial Officer
Facsimile: (04) 604-7242
with a copy to: Yigal Arnon & Co.
1 Azrieli Center
46th Floor, The Round Tower
Tel Aviv
Israel
Attention: David H. Schapiro, Adv.
Facsimile: (03) 608-7714

Each of the above addressees may change its address for purposes of this paragraph by giving to the other addressees notice of such new address in conformance with this paragraph.

 

13


14. APPLICABLE LAW; JURISDICTION

This Warrant shall be governed by and construed in accordance with the laws of the State of Israel as applicable to contracts between two residents of the State of Israel entered into and to be performed entirely within the State of Israel. Any dispute arising under or in relation to this Warrant shall be resolved in the competent court for Tel Aviv-Jaffa district, and each of the parties hereby submits irrevocably to the jurisdiction of such court.

Dated: October 27, 2014

 

for TOWER SEMICONDUCTOR LTD.
By: /s/ Oren Shirazi /s/ Yoram Glatt
 

 

Title: CFO Treasurer
 

 

 

14

EX-18 6 d887643dex18.htm EX-18 EX-18

Exhibit 18

2014 AMENDMENT

to

AMENDED AND RESTATED

REGISTRATION RIGHTS AGREEMENT

 

 

THIS 2014 AMENDMENT is made on the 27th day of October, 2014, between:

 

  (1) TOWER SEMICONDUCTOR LTD., a company incorporated in Israel (registered number 52–004199–7), having its registered office at P.O. Box 619, Migdal Haemek 23105, Israel (the Company);

and

 

  (2) BANK HAPOALIM B.M. (“the Bank”)

WHEREAS:

 

(A) this registration rights agreement was originally entered into on September 28, 2006 between the Company and the Bank and amended and restated by the parties on September 25, 2008 and further amended on October 13, 2009 (“the Agreement”); and

 

(B) at the request of the Company, the Company and the Banks entered into a letter agreement, dated October 27, 2014 (“the 2014 Consent Letter”), pursuant to which the Banks, inter alia, extended the repayment schedule of the loans under the Facility Agreement and the Company, inter alia, agreed to issue an additional Warrant to the Bank and to enter into this 2014 Amendment (“this Amendment”) to the Agreement,


NOW THEREFORE IT IS AGREED BETWEEN THE PARTIES HERETO AS FOLLOWS:

 

1. Unless otherwise defined in this Amendment, terms defined and references contained in the Agreement, shall have the same meaning and construction in this Amendment.

 

2. The Agreement is hereby amended as follows:

 

2.1. The following new definitions (r) and (s)are hereby added to Section 1 (“Definitions and Interpretation”):

 

  “(r) “2014 Consent Letter” means the letter agreement, dated October 27, 2014, pursuant to which the Banks, inter alia, extended the repayment schedule of the loans under the Facility Agreement.

 

  (s) “2014 Warrant” means the Warrant granted by the Company to the Bank effective as of October 27, 2014 pursuant to the 2014 Consent Letter.”

 

2.2. Existing definition (“Tarshish”) is renumbered (without any further changes) as definition (t) and existing definition (s) (“Warrant”) is hereby renumbered and amended to read in its entirety as follows:

 

  “(u) “Warrant” means the 2003 Warrant, the 2005 Warrant, the 2007 Warrant, the 2009 Warrant, the 2010 Warrant, the 2011 Warrant and the 2014 Warrant or any of them or any portion thereof as any of such Warrants may be amended at any time and from time to time.”

 

3. Save as amended expressly pursuant to this Amendment, the provisions of the Agreement shall continue in full force and effect and the Agreement and this Amendment shall be read and construed as one instrument.

 

4. This Amendment shall be governed by and construed in accordance with the laws of the State of Israel.

 

2


IN WITNESS WHEREOF, the parties have signed this 2014 Amendment on the 27th day of October 2014.

 

for: TOWER SEMICONDUCTOR LTD.
By: /s/ Oren Shirazi /s/ Yoram Glatt
 

 

Title CFO Treasurer
 

 

for: BANK HAPOALIM B.M.
By: /s/ Irit Beahar /s/ Irit Sigman
 

 

Title Department Manager Section Manager
 

 

 

3